Filing Details

Accession Number:
0001127602-11-020595
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-07-05 16:25:06
Reporting Period:
2011-07-01
Filing Date:
2011-07-05
Accepted Time:
2011-07-05 16:25:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874663 Alkermes Inc ALKS Pharmaceutical Preparations (2834) 232472830
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236441 A Robert Breyer 852 Winter St.
Waltham MA 02451
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-07-01 3,025 $7.19 67,181 No 4 M Direct
Common Stock Disposition 2011-07-01 3,025 $18.55 64,156 No 4 S Direct
Common Stock Disposition 2011-07-01 3,025 $18.55 61,131 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non Qualified Stock Option (Right to Buy) Disposition 2011-07-01 3,025 $0.00 3,025 $7.19
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,425 2003-03-18 2012-09-18 No 4 M Direct
Footnotes
  1. This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  3. This option became exercisable in full six months from the date of grant.